Targeting the Calcineurin Homologous Protein 1 (CHP1)-Transmembrane Protein 87A (TMEM87A) mechanosensing complex: a druggable vulnerability in metastatic ovarian cancer
Ming-Zhu Jin, Heng-An Liu, Wen Di · 2026
Read Targeting the Calcineurin Homologous Protein 1 (CHP1)-Transmembrane Protein 87A (TMEM87A) mechanosensing complex: a druggable vulnerability in metastatic ovarian cancer by Ming-Zhu Jin, Heng-An Liu, Wen Di (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13247001.txt.
Description
Jin, Liu, Di, and co-authors identified a force-sensing protein pair that helps ovarian cancer spread, in this 2026 Molecular Biomedicine paper. High-grade serous ovarian cancer kills by scattering through the abdomen, which requires tumor cells to survive after detaching, a step many cancers fail. Searching gene data linked to tissue sugar metabolism, the team landed on a protein called CHP1 and its partner TMEM87A.
Removing either protein wrecked the tumor spheroids' structure in laboratory models and sharply reduced tumor growth and spread in mice, apparently by quieting a growth-signaling pathway. A repurposed compound, sodium gluconate, broke the pair apart and shrank tumors at low doses without obvious organ damage. The authors propose the complex as a druggable weak point in metastatic disease.
Catalog record
| CREATOR | Ming-Zhu Jin, Heng-An Liu, Wen Di |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |